News

Panel calls new hepatitis C drug ‘low value’

Posted on: 12/03/2014 - 21:05

A panel of California medical experts says two new, once-daily drugs for hepatitis C represent low-value treatment alternatives for the condition because of their high price tags. The drugs, Gilead...

Field of Interest: Infectious diseases
Type: News Item

Panel calls new hepatitis C drug ‘low value’

Posted on: 12/03/2014 - 21:05

A panel of California medical experts says two new, once-daily drugs for hepatitis C represent low-value treatment alternatives for the condition because of their high price tags. The drugs, Gilead...

Field of Interest: Gastroentero...
Type: News Item

Two definitions of Gulf War illness recommended

Posted on: 12/03/2014 - 15:30

An Institute of Medicine committee could not reach consensus on a single definition of Gulf War illness and recommended in a new report that clinicians and researchers at least narrow it down to two...

Field of Interest: Gastroentero...
Type: News Item

Two definitions of Gulf War illness recommended

Posted on: 12/03/2014 - 15:30

An Institute of Medicine committee could not reach consensus on a single definition of Gulf War illness and recommended in a new report that clinicians and researchers at least narrow it down to two...

Field of Interest: Dermatology
Type: News Item

Nivolumab extends survival in advanced melanoma

Posted on: 12/03/2014 - 14:15

An immunomodulator that targets the PD-1 pathway effected sustained remission in 31% of patients who took it for advanced melanoma. Remission lasted a median of 2 years, with 1- and 2-year overall...

Field of Interest: Oncology
Type: News Item

Team planning cuts pancreatectomy readmissions

Posted on: 11/03/2014 - 19:05

MIAMI BEACH – A combination of teamwork and leadership led to a 50% reduction in readmission after pancreatectomy in a large academic facility. The readmission rate at Indiana University Hospital...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More